Computational Studies of Satureja hortensis Phytochemicals as Inhibitors of AP ‐1 ( FOS / JUN ) Activation in Valproic Acid Teratogenicity
Birth Defects Research · 2026-05 · 118 (5)
DOI: 10.1002/bdr2.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research, online erschienen am 06.05.2026. Verfasst von Vindya Nagarakere Shankara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G Nagara, India. Hauptthemen laut MEDLINE: Valproic Acid, Transcription Factor AP-1, Phytochemicals, Satureja. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Valproic acid (VPA) is a widely used antiepileptic drug and known teratogen that induces developmental defects in part via aberrant activation of the AP‐1 (c‐Fos/c‐Jun) transcription factor pathway. We investigated whether phytochemicals from Satureja hortensis L. (summer savory) can modulate this pathway.
Methods
In this study, we employed structure‐based computational methods to screen phytoconstituents of S. hortensis against the AP‐1 (Fos/Jun) transcription factor.
Results
Molecular docking predicted that the top ligands, cedrelanol and allo‐aromadendrene, bound the DNA‐bound AP‐1 complex (1FOS) with affinities of −7.7 kcal/mol each, exceeding the −7.3 kcal/mol affinity of the reference inhibitor SR11302. Subsequent 100‐ns molecular dynamics simulation of the cedrelanol‐1FOS complex confirmed stable binding the protein backbone RMSD remained between 0.8–1.2 Å and the ligand RMSD stayed below 1.3 Å throughout the trajectory. MM/GBSA binding free energy analysis further indicated a highly favorable ΔG_binding of −75.04 kcal/mol for the cedrelanol‐1FOS complex.
Conclusion
These integrated results highlight cedrelanol as a potent AP‐1 modulator, providing a molecular basis for exploring S. hortensis terpenoids to mitigate VPA‐induced teratogenic AP‐1 hyperactivation. These findings suggest that S. hortensis phytochemicals as plausible inhibitors of AP‐1, with potential implications for developing plant‐derived agents to mitigate VPA teratogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G Nagara, India.
- Department of Pharmacology, Al-Ameen College of Pharmacy, Bengaluru, India.
ORCID-Profile: Vindya Nagarakere Shankara, Bharathi Doddla Raghunathanaidu
Zitieren
APA
Nagarakere Shankara, V., Ahmed, S. S., & Doddla Raghunathanaidu, B. (2026). Computational Studies of Satureja hortensis Phytochemicals as Inhibitors of AP ‐1 ( FOS / JUN ) Activation in Valproic Acid Teratogenicity. Birth Defects Research, 118(5). https://doi.org/10.1002/bdr2.70054
Vancouver
Nagarakere Shankara V, Ahmed SS, Doddla Raghunathanaidu B. Computational Studies of Satureja hortensis Phytochemicals as Inhibitors of AP ‐1 ( FOS / JUN ) Activation in Valproic Acid Teratogenicity. Birth Defects Research. 2026;118(5). doi:10.1002/bdr2.70054
BibTeX
@article{NagarakereShankara2026,
author = {Nagarakere Shankara, Vindya and Ahmed, Syed Sagheer and Doddla Raghunathanaidu, Bharathi},
title = {Computational Studies of Satureja hortensis Phytochemicals as Inhibitors of AP ‐1 ( FOS / JUN ) Activation in Valproic Acid Teratogenicity},
journal = {Birth Defects Research},
year = {2026},
volume = {118},
number = {5},
doi = {10.1002/bdr2.70054}
}
EUVIMED